Study shows age doesn’t affect survival outcomes in patients with MDS who receive a HCT

Prospective study, presented at the 57th Annual Meeting of the American Society of Hematology, shows age doesn’t affect survival outcomes in patients with myelodysplastic syndrome (MDS) who receive a hematopoietic cell transplant. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail